Asthma & COPD Market, By Drug Type (Bronchodilators (Short Acting Bronchodilators, Long Acting Bronchodilators, Anticholinergics), Anti-Inflammatories (Inhaled Corticosteroids, Anti-Leukotriene, Monoclonal Antibodies), Combination Therapies), By Disease T

Asthma & COPD Market, By Drug Type (Bronchodilators (Short Acting Bronchodilators, Long Acting Bronchodilators, Anticholinergics), Anti-Inflammatories (Inhaled Corticosteroids, Anti-Leukotriene, Monoclonal Antibodies), Combination Therapies), By Disease Type (Asthma, COPD), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Drug Stores), and By Region (North America, Latin America, Europe Asia, Pacific Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Asthma is a type of chronic respiratory disease, which is characterized by attacks of breathlessness and wheezing. Asthma can occur at any stage, though it is the most common disease in children. Asthma attacks are linked to respiratory infections and environmental factors such as allergens, tobacco, smoke, and indoor and outdoor pollution. Indoor pollution factors include mold, chemicals, strong odors, and house dust whereas outdoor pollution factors include air pollution, allergens, tobacco, and smoking. Such factors are responsible for development and exacerbation of asthma.
Restraints of the Global Asthma and COPD Market
Major factors hampering the growth of the asthma and COPD market during the forecast period constitutes of patent losses, and high costs.
Key features of the study:
This report provides in-depth analysis of the global asthma and COPD market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021, as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
It profiles leading players in the global asthma and COPD market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include AstraZeneca, Novartis AG, GlaxoSmithKline plc, Merck & Co., Verona Pharma plc,, Regeneron Pharmaceuticals, Inc., GlaxoSmithKline plc, and Boehringer Ingelheim GmbH.
Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
The global asthma and COPD market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.
Detailed Segmentation
Global Asthma and COPD Market, By Drug Type:
Bronchodilators
Short Acting Bronchodilators
Long Acting Bronchodilators
Anticholinergics
Anti-Inflammatories
Inhaled Corticosteroids
Anti-Leukotriene
Monoclonal Antibodies
Combination Therapies
Global Asthma and COPD Market, By Disease Type:
Asthma
COPD
Global Asthma and COPD Market, By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Drug Stores
Global Asthma and COPD Market, By Geography:
North America
By Drug Type
Bronchodilators
Short Acting Bronchodilators
Long Acting Bronchodilators
Anticholinergics
Anti-Inflammatories
Inhaled Corticosteroids
Anti-Leukotriene
Monoclonal Antibodies
Combination Therapies
By Disease Type
Asthma
COPD
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Drug Stores
By Country:
U.S.
Canada
Europe
By Drug Type
Bronchodilators
Short Acting Bronchodilators
Long Acting Bronchodilators
Anticholinergics
Anti-Inflammatories
Inhaled Corticosteroids
Anti-Leukotriene
Monoclonal Antibodies
Combination Therapies
By Disease Type
Asthma
COPD
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Drug Stores
By Country:
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
By Drug Type
Bronchodilators
Short Acting Bronchodilators
Long Acting Bronchodilators
Anticholinergics
Anti-Inflammatories
Inhaled Corticosteroids
Anti-Leukotriene
Monoclonal Antibodies
Combination Therapies
By Disease Type
Asthma
COPD
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Drug Stores
By Country:
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
By Drug Type
Bronchodilators
Short Acting Bronchodilators
Long Acting Bronchodilators
Anticholinergics
Anti-Inflammatories
Inhaled Corticosteroids
Anti-Leukotriene
Monoclonal Antibodies
Combination Therapies
By Disease Type
Asthma
COPD
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Drug Stores
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Middle East:
By Drug Type
Bronchodilators
Short Acting Bronchodilators
Long Acting Bronchodilators
Anticholinergics
Anti-Inflammatories
Inhaled Corticosteroids
Anti-Leukotriene
Monoclonal Antibodies
Combination Therapies
By Disease Type
Asthma
COPD
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Drug Stores
By Country:
GCC
Israel
Rest of Middle East
Africa
By Drug Type
Bronchodilators
Short Acting Bronchodilators
Long Acting Bronchodilators
Anticholinergics
Anti-Inflammatories
Inhaled Corticosteroids
Anti-Leukotriene
Monoclonal Antibodies
Combination Therapies
By Disease Type
Asthma
COPD
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Drug Stores
By Country/Region:
Central Africa
South Africa
North Africa
Company Profiles
AstraZeneca PLC*
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
Novartis AG
GlaxoSmithKline plc
Merck & Co., Inc.
Verona Pharma plc
Regeneron Pharmaceuticals, Inc.
Boehringer Ingelheim GmbH
“*” marked represents similar segmentation in other categories in the respective section.